Jacobs Levy Equity Management’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
VPM
VCM
NAMI
Jacobs Levy Equity Management's OMCL Position: Q1 2026 in Review
Jacobs Levy Equity Management increased its Omnicell (OMCL) stake by 569% in Q1 2026, buying an estimated $17.9M and bringing the position to 502,700 shares worth $16.8M. The position accounts for 0.07% of the portfolio, ranked #231.
Jacobs Levy Equity Management first reported a position in OMCL in Q2 2013 and has held it in 11 quarters since. The position peaked at $21.7M in Q3 2023. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.
- Jacobs Levy Equity Management held 502,700 shares of Omnicell worth $16.8M as of Q1 2026.
- Jacobs Levy Equity Management bought 427,507 Omnicell shares in Q1 2026, an estimated $17.9M.
- Omnicell made up 0.07% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #231 holding.
- Jacobs Levy Equity Management first reported a position in Omnicell in Q2 2013 and has held it in 11 quarters since.
- Jacobs Levy Equity Management's Omnicell position peaked at $21.7M in Q3 2023.
- 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.